Endocrine symptoms to predict risk of recurrence?
Pritchard
Kathleen I
KI
D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000009:adverse effects*; D018771:Arthralgia / Q000139:chemically induced; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000517:prevention & control*; D005260:Female; D019584:Hot Flashes / Q000139:chemically induced; D006801:Humans; D007596:Joints / Q000187:drug effects*; D055118:Medication Adherence; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy* / Q000517:prevention & control*; D011237:Predictive Value of Tests; D016896:Treatment Outcome; D014666:Vasomotor System / Q000187:drug effects*
D018931:Antineoplastic Agents, Hormonal